We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company

News  
Published: August 11, 2006
 

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖
Read time:
 

Digilab BioVisioN and Novartis will continue and expand their cooperation in the field of biomarker discovery in drug treatment studies.

Digilab BioVisioN announced the closure of a new agreement applying their Peptidomics® technology in the quantitative characterization of the peptides in biological samples (the peptidome) with the aim to discover potential biomarkers.

Apart from a research payment, Digilab BioVisioN will receive milestone payments and royalties as success payments. The contract continues a successful cooperation of both companies dating from 2004.

Related Topic Pages
Biomarkers
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter